Logo image of ALEC

ALECTOR INC (ALEC) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ALEC - US0144421072 - Common Stock

1.86 USD
+0.09 (+5.08%)
Last: 1/9/2026, 8:00:00 PM
1.8 USD
-0.06 (-3.23%)
After Hours: 1/9/2026, 8:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALEC. ALEC was compared to 530 industry peers in the Biotechnology industry. Both the profitability and financial health of ALEC have multiple concerns. While showing a medium growth rate, ALEC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALEC had negative earnings in the past year.
ALEC had a negative operating cash flow in the past year.
ALEC had negative earnings in each of the past 5 years.
ALEC had negative operating cash flow in 4 of the past 5 years.
ALEC Yearly Net Income VS EBIT VS OCF VS FCFALEC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

ALEC has a better Return On Assets (-32.13%) than 65.47% of its industry peers.
The Return On Equity of ALEC (-186.68%) is worse than 66.42% of its industry peers.
Industry RankSector Rank
ROA -32.13%
ROE -186.68%
ROIC N/A
ROA(3y)-21.11%
ROA(5y)-21.34%
ROE(3y)-84.42%
ROE(5y)-67.29%
ROIC(3y)N/A
ROIC(5y)N/A
ALEC Yearly ROA, ROE, ROICALEC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALEC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALEC Yearly Profit, Operating, Gross MarginsALEC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K

More info and screens

3

2. Health

2.1 Basic Checks

ALEC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALEC has more shares outstanding
Compared to 5 years ago, ALEC has more shares outstanding
The debt/assets ratio for ALEC is higher compared to a year ago.
ALEC Yearly Shares OutstandingALEC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ALEC Yearly Total Debt VS Total AssetsALEC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -3.71, we must say that ALEC is in the distress zone and has some risk of bankruptcy.
ALEC has a Altman-Z score (-3.71) which is in line with its industry peers.
ALEC has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
ALEC's Debt to Equity ratio of 0.17 is on the low side compared to the rest of the industry. ALEC is outperformed by 64.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -3.71
ROIC/WACCN/A
WACC8.72%
ALEC Yearly LT Debt VS Equity VS FCFALEC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

2.3 Liquidity

A Current Ratio of 3.76 indicates that ALEC has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.76, ALEC is in line with its industry, outperforming 45.66% of the companies in the same industry.
ALEC has a Quick Ratio of 3.76. This indicates that ALEC is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ALEC (3.76) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.76
Quick Ratio 3.76
ALEC Yearly Current Assets VS Current LiabilitesALEC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

ALEC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.06%, which is quite impressive.
Looking at the last year, ALEC shows a quite strong growth in Revenue. The Revenue has grown by 12.26% in the last year.
ALEC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.53% yearly.
EPS 1Y (TTM)37.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.93%
Revenue 1Y (TTM)12.26%
Revenue growth 3Y-21.4%
Revenue growth 5Y36.53%
Sales Q2Q%-78.75%

3.2 Future

The Earnings Per Share is expected to grow by 6.37% on average over the next years.
The Revenue is expected to decrease by -20.72% on average over the next years. This is quite bad
EPS Next Y-19.83%
EPS Next 2Y3.25%
EPS Next 3Y-1.27%
EPS Next 5Y6.37%
Revenue Next Year-72.83%
Revenue Next 2Y-16.63%
Revenue Next 3Y-24.63%
Revenue Next 5Y-20.72%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALEC Yearly Revenue VS EstimatesALEC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
ALEC Yearly EPS VS EstimatesALEC Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALEC. In the last year negative earnings were reported.
Also next year ALEC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALEC Price Earnings VS Forward Price EarningsALEC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALEC Per share dataALEC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.25%
EPS Next 3Y-1.27%

More info and screens

0

5. Dividend

5.1 Amount

ALEC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ALECTOR INC

NASDAQ:ALEC (1/9/2026, 8:00:00 PM)

After market: 1.8 -0.06 (-3.23%)

1.86

+0.09 (+5.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners82.44%
Inst Owner Change0%
Ins Owners6.49%
Ins Owner Change-0.4%
Market Cap203.02M
Revenue(TTM)69.05M
Net Income(TTM)-107.74M
Analysts51.43
Price Target2.09 (12.37%)
Short Float %6.43%
Short Ratio2.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.13%
Min EPS beat(2)18.2%
Max EPS beat(2)36.06%
EPS beat(4)4
Avg EPS beat(4)42.08%
Min EPS beat(4)17.12%
Max EPS beat(4)96.92%
EPS beat(8)8
Avg EPS beat(8)34.42%
EPS beat(12)11
Avg EPS beat(12)32.87%
EPS beat(16)12
Avg EPS beat(16)3.34%
Revenue beat(2)2
Avg Revenue beat(2)93.28%
Min Revenue beat(2)5.84%
Max Revenue beat(2)180.71%
Revenue beat(4)3
Avg Revenue beat(4)97.2%
Min Revenue beat(4)-17.7%
Max Revenue beat(4)219.92%
Revenue beat(8)6
Avg Revenue beat(8)55.89%
Revenue beat(12)8
Avg Revenue beat(12)123.78%
Revenue beat(16)9
Avg Revenue beat(16)90.6%
PT rev (1m)-6.82%
PT rev (3m)-46.52%
EPS NQ rev (1m)0.39%
EPS NQ rev (3m)-7.84%
EPS NY rev (1m)1.41%
EPS NY rev (3m)5.76%
Revenue NQ rev (1m)33.31%
Revenue NQ rev (3m)9.2%
Revenue NY rev (1m)1.87%
Revenue NY rev (3m)5.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.94
P/FCF N/A
P/OCF N/A
P/B 3.52
P/tB 3.52
EV/EBITDA N/A
EPS(TTM)-1.07
EYN/A
EPS(NY)-1.15
Fwd EYN/A
FCF(TTM)-1.81
FCFYN/A
OCF(TTM)-1.81
OCFYN/A
SpS0.63
BVpS0.53
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -32.13%
ROE -186.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-21.11%
ROA(5y)-21.34%
ROE(3y)-84.42%
ROE(5y)-67.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.23%
Cap/Sales 0.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.76
Quick Ratio 3.76
Altman-Z -3.71
F-Score3
WACC8.72%
ROIC/WACCN/A
Cap/Depr(3y)45.58%
Cap/Depr(5y)54.45%
Cap/Sales(3y)2.26%
Cap/Sales(5y)6.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.93%
EPS Next Y-19.83%
EPS Next 2Y3.25%
EPS Next 3Y-1.27%
EPS Next 5Y6.37%
Revenue 1Y (TTM)12.26%
Revenue growth 3Y-21.4%
Revenue growth 5Y36.53%
Sales Q2Q%-78.75%
Revenue Next Year-72.83%
Revenue Next 2Y-16.63%
Revenue Next 3Y-24.63%
Revenue Next 5Y-20.72%
EBIT growth 1Y32.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.81%
EBIT Next 3Y4.76%
EBIT Next 5Y9.32%
FCF growth 1Y-4.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.54%
OCF growth 3YN/A
OCF growth 5YN/A

ALECTOR INC / ALEC FAQ

What is the ChartMill fundamental rating of ALECTOR INC (ALEC) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALEC.


What is the valuation status of ALECTOR INC (ALEC) stock?

ChartMill assigns a valuation rating of 0 / 10 to ALECTOR INC (ALEC). This can be considered as Overvalued.


Can you provide the profitability details for ALECTOR INC?

ALECTOR INC (ALEC) has a profitability rating of 1 / 10.


How financially healthy is ALECTOR INC?

The financial health rating of ALECTOR INC (ALEC) is 3 / 10.